Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

the webinar is about to start..

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Alex125 Member Profile
 
Followed By 5
Posts 185
Boards Moderated 0
Alias Born 09/16/10
160x600 placeholder
Anavex Life Sciences to Present at the 2021 Cantor Virtual Global Healthcare Conference GlobeNewswire Inc. - 9/20/2021 7:00:00 AM
CEO Presenting on the Emerging Growth Conference Today!  Register Now InvestorsHub NewsWire - 9/15/2021 7:00:00 AM
Anavex Life Sciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference GlobeNewswire Inc. - 9/9/2021 7:00:00 AM
CEO Presenting on the Emerging Growth Conference Today.  Register Now InvestorsHub NewsWire - 9/1/2021 7:00:00 AM
Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Autism) GlobeNewswire Inc. - 8/26/2021 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/12/2021 5:13:54 PM
Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Third Quarter Financial Results GlobeNewswire Inc. - 8/12/2021 7:00:00 AM
Anavex Life Sciences to Announce Fiscal 2021 Third Quarter Financial Results on Thursday, August 12, 2021 GlobeNewswire Inc. - 8/5/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/4/2021 5:41:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/4/2021 5:39:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/4/2021 5:36:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/4/2021 5:31:15 PM
CEO Presenting on the Emerging Growth Conference Today.  Register Now InvestorsHub NewsWire - 8/4/2021 7:00:00 AM
Anavex Life Sciences to Participate in the BTIG Virtual Biotechnology Conference 2021 GlobeNewswire Inc. - 8/4/2021 7:00:00 AM
Cassava Sciences drags rivals lower amid concerns over its Alzheimer’s drug Seeking Alpha - 7/30/2021 9:03:44 AM
Anavex Life Sciences rises on positive data for Alzheimer’s therapy in mouse study Seeking Alpha - 7/29/2021 7:46:45 AM
Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Significantly Prevented Aβ (Abeta)-induced Cognitive Deficits with Confirmed Significant Biomarker-response in Animal Model of Alzheimer’s Disease GlobeNewswire Inc. - 7/29/2021 7:00:00 AM
Nightfood, Inc. (OTCQB: NGTF) Significant Retail Expansion InvestorsHub NewsWire - 7/21/2021 6:47:54 AM
CEO Presenting on the Emerging Growth / Investors Hub Joint Conference on July 21 InvestorsHub NewsWire - 7/20/2021 7:00:00 AM
Alzheimer's drug players shake off concerns from Biogen aducanunab probe Seeking Alpha - 7/12/2021 10:20:38 AM
CEO Presenting on the Second Emerging Growth / Investors Hub Joint Conference on July 7. InvestorsHub NewsWire - 7/5/2021 7:00:00 AM
WNRS Upgraded To BUY InvestorsHub NewsWire - 7/1/2021 9:36:27 AM
Sino United (OTC Pink: SUIC) $200 Million Commitment, Signs with Suntech, the Largest Taiwan O2O Company. InvestorsHub NewsWire - 6/30/2021 7:30:00 AM
Anavex posts the sharpest one-day loss in over seven months Seeking Alpha - 6/29/2021 4:49:18 PM
Anavex posts the sharpest one-day loss in over seven months Seeking Alpha - 6/29/2021 4:47:49 PM
Alex125   Tuesday, 01/12/21 02:25:28 PM
Re: A deleted message
Post # of 330557 
the webinar is about to start..

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences